Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Announces Results from Its Annual General Meeting

GlobeNewswire April 10, 2018

Avivagen Announces an Amendment to its Stock Option Plan

GlobeNewswire April 5, 2018

Avivagen Announces Continued Growth and Adoption in the Commercial Use of OxC-beta™ Livestock in the Philippines

GlobeNewswire March 26, 2018

Cesar Millan’s Highly Recommended Vivamune™ Scheduled for Global Pet Expo Debut

GlobeNewswire March 19, 2018

Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants

GlobeNewswire March 12, 2018

Avivagen Announces CEO Update and January 31, 2018 Financial First Quarter Results

GlobeNewswire February 27, 2018

Avivagen Announces Two Year Distribution Agreement with PACC Pets and Attendance at Global Pet Expo

GlobeNewswire February 23, 2018

Avivagen Announces Positive Results from Swine Trial

GlobeNewswire January 15, 2018

Avivagen Announces Positive Results from Dairy Cattle Trial

GlobeNewswire January 8, 2018

Avivagen Inc. Announces the Granting of Options

GlobeNewswire December 22, 2017

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2017

GlobeNewswire December 20, 2017

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

GlobeNewswire December 8, 2017

IIROC Trading Resumption - VIV

Canada NewsWire November 30, 2017

IIROC Trade Resumption - Avivagen Inc.

Newsfile November 30, 2017

Avivagen Announces Closing of Private Placement Totaling $4 million

GlobeNewswire November 30, 2017

IIROC Trading Halt - VIV

Canada NewsWire November 30, 2017

IIROC Trade Halt - Avivagen Inc.

Newsfile November 30, 2017

Avivagen Announces the Appointment of Mr. Aubrey Dan to the Board of Directors

GlobeNewswire November 22, 2017

CEO Kym Anthony Discusses 2017 Miles Stones and Product Developments

GlobeNewswire November 13, 2017

Cesar Millan helps Avivagen Relaunch Vivamune™ Health Chews in U.S.

GlobeNewswire October 23, 2017